Children's Mercy Kansas City

SHARE @ Children's Mercy
Posters
10-2022

Stewardship Opportunities for Cervical Lymphadenitis and Deep
Neck Space Infections
Aaron Shaw
Brian R. Lee
Lauren Kazmaier
Emily Baker
Tina Dao

See next page for additional authors

Follow this and additional works at: https://scholarlyexchange.childrensmercy.org/posters
Part of the Infectious Disease Commons

Authors
Aaron Shaw, Brian R. Lee, Lauren Kazmaier, Emily Baker, Tina Dao, Sandra Arnold, and Angela Myers

Stewardship Opportunities for Cervical Lymphadenitis
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INTRODUCTION
•

•

•

Cervical lymphadenitis (LAD) and deep neck
space abscesses (DNSA) are common pediatric
infections caused by similar bacteria

There are no standardized guidelines available to
guide diagnosis and antibiotic therapy, resulting
in variation between and within institutions
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Charts obtained using ICD9/ICD10 codes
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Dates: 1/1/10-12/31/20 at 2 institutions:
Children’s Mercy Hospital (CMH) and Le Bonheur
Children’s Hospital (LBCH)
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1981 charts identified
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Collected information on presenting symptoms,
imaging, antibiotics, microbiology, steroids, and
surgery
Included diagnoses: Cervical lymphadenitis,
retropharyngeal and parapharyngeal abscesses
Excluded: inflammatory or autoimmune
conditions, viruses, atypical bacteria (e.g.
tuberculosis, nontuberculous mycobacteria,
tularemia)

•

S. pyogenes most often isolated bacteria in DNSA
cultures; S. aureus more common in LAD (Table 1)

•

Gram negative organisms accounted for <5% of all
DNSA, <2% of all LAD cases

Age (in years)

2.0 [1.0, 4.6]

4.0 [1.9,6.4]

<0.0001

Gender (Male)

409 (53.3%)

402 (60.5%)

0.008

•

Antibiotics: Clindamycin most used antibiotic in
both groups (Figure 3)

0.026

•

Ceftriaxone used more frequently in DNSA cases,
but almost always in combination with clindamycin
(Figure 3)

•

Ampicillin sulbactam used significantly more often
with cases of DNSA, though less often than
clindamycin or clindamycin + ceftriaxone (Figure 3)

•

More likely to use ≥2 antibiotics in DNSA but still
frequently used in LAD (Table 1)

60.00%

10.00%

•

Microbiology: Most patients in both groups had a
blood culture obtained. These were negative in
≥95% of all cases

LAD (n=767)

90.00%

40.00%

•

•

Table 1. Demographics,
Culture Results, and
Antibiotic Therapy

70.00%

METHODS

Imaging: CT scans were used in nearly all DNSA
cases, compared to 69% in the LAD group. Only 8%
in the DNSA group had an ultrasound, in contrast
to half the LAD group (Figure 2)
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Presenting Symptoms by Diagnosis
We sought to determine differences in
presentation, diagnosis, and treatment between
LAD and DNSA cases to identify antimicrobial
and diagnostic stewardship opportunities

•

Race
-Black
-White

338 (44.1%)
310 (40.4%)

253 (38.0%)
315 (47.4%)

Blood culture:
-Negative

N=492 (64.2%)
480 (97.6%)

N=424 (63.8%)
403 (95.0%)

Abscess Culture
-Negative
-S. pyogenes
-MRSA
-MSSA
-Gram negative organisms*

N=280
55 (19.6%)
34 (12.1%)
92 (32.9%)
78 (27.9%)
5 (1.78%)

N=331
63 (19.0%)
121 (36.6%)
48 (14.5%)
27 (8.2%)
15 (4.53%)

Antibiotics:
1
2+

N=762
283 (37.1%)
479 (62.9%)

N=664
129 (19.4%)
535 (80.6%)

0.05

0.918
<0.001
<0.001
<0.001

<0.001

DISCUSSION

*H. influenzae, Eikenella, Kingella, E. coli, K. pneumoniae, M. catarrhalis
LAD (N=401)

*p<0.001

DNSA (N=359)

Figure 3

Antibiotic Selections* By Diagnosis

•

Presenting symptoms may be able to help
clinicians distinguish between these two similar
infections, which may inform decisions on what
imaging to obtain and which antibiotics to start

•

CT scans are often used in cases of LAD when an
ultrasound may be a viable alternative

•

Blood cultures are unlikely to be positive in
either disease process and may not need to be
obtained

•

92.5% of LAD had negative abscess cultures or
were caused by S. pyogenes or S. aureus

•

Omission of empiric Gram negative coverage
(ceftriaxone) from cases of LAD is reasonable

100%

Figure 2

Imaging Usage by Diagnosis
90%

80%

RESULTS
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MRI
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•

1432 patients included; 760 from CMH, 672
from LBCH

50%
40%

Ultrasound

•

•

Demographics: patients with DNSA were older;
minor differences in gender and race were
noted between groups (Table 1)
Symptoms: DNSA patients were more likely to
present with symptoms of drooling, dysphagia,
hoarseness, and sore throat. LAD patients more
often had neck swelling and skin color changes
(Figure 1)
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LAD (N=759)
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DNSA (N=664)

Clinda + ceftriaxone

*Four most selected antibiotic regimens

